Array Market (Life Science and Biotechnology Instruments) Regional Analysis

Array Market (Life Science and Biotechnology Instruments), By Type, By End User, And By Region (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa) -

Published In : Aug 2023

Code : CMI4221

Pages :247

Formats :

Excel and PDF

Industry : Medical Devices

Regional Analysis

Global Array Market (Life Science and Biotechnology Instruments) - Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global array market (Life Science and Biotechnology Instruments) over the forecast period. This is attributed to the increasing number of clinical trials conducted by market players. For instance, on June 5, 2023, Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, announced positive interim results from a Phase I human clinical trial with the first needle-free COVID-19 vaccine candidate delivered using Vaxxas’ proprietary high-density microarray patch (HD-MAP) technology.

North America: U.S. and Canada

Latin America: Brazil, Argentina, Mexico, and Rest of Latin America

Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe

Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific

Middle East: GCC Countries, Israel, and Rest of Middle East

Africa: South Africa, North Africa, and Central Africa